International Journal of Nutrition
ISSN: 2379-7835
Current Issue
Volume No: 3 Issue No: 4
share this page

Research Article | Open Access
  • Available online freely | Peer Reviewed
  • Antibacterial and Cytotoxicity Activities of Major Compounds from Tinospora cordifolia Willd. Growing on Mangifera indica L.

    Thongchai Taechowisan 1      

    1Department of Biology, Faculty of Science, Silpakorn University, Nakorn Pathom 73000, Thailand.



    To investigate the major constituents of Tinosporacordifolia Willd. growing on Mangiferaindica, and to evaluate the efficacy of their antibacterial and cytotoxicity activities.


    The ethanolic stem extract of T. cordifolia was subjected to silica gel 60 column chromatography, thin layer chromatography and medium pressure liquid chromatography for isolation of the major compounds. Identification of purified compounds was achieved by spectroscopic methods.. The crude extract and purified compounds were screened for their antibacterial and cytotoxicity properties using standard procedures.


    Two alkaloids were purified and identified as Magnoflorin (1) and Tembetarine (2). These compounds showed high antibacterial activity against Bacillus cereus and Staphylococcus aureus with both MIC (32-64 µg/ml) and MBC (128-256 µg/ml). The cytotoxicity activity of the purified compounds and crude extract was determined using MTT colorimetric assay against L929 and HEK293 cell lines. This showed weak cytotoxicity activity with IC50 values of 1162.24 to 2290.00 µg/ml and 1376.67 to 2585.06 µg/ml towards L929 and HEK293 cell lines, respectively.


    The major compounds present in ethanolic stem extract of T. cordifolia growing on M. indica were extracted, purified and identified. This study suggests that these compounds exhibit great potential for antibacterial activity with weak cytotoxicity activity. They may be useful for their medicinal functions.

    Received 25 Feb 2019; Accepted 20 Mar 2019; Published 03 Apr 2019;

    Academic Editor:Shuai Chen,

    Checked for plagiarism: Yes

    Review by: Single-blind

    Copyright©  2019 Thongchai Taechowisan

    Creative Commons License    This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    Competing interests

    The authors have declared that no competing interest exists.


    Thongchai Taechowisan (2019) Antibacterial and Cytotoxicity Activities of Major Compounds from Tinospora cordifolia Willd. Growing on Mangifera indica L. . International Journal of Nutrition - 3(4):32-42.
    Download as RIS, BibTeX, Text (Include abstract )


    Tinosporacordifolia Willd. is a herbaceous vine of the family Menispermaceae. It was known in Thailand as "Boraphet" and was a glabrous climbing shrub found throughout the tropical regions of south east Asia. In Ayurveda, T. cordifolia was known as the king of medicinal plants for treating various ailments. It was an antispasmodic, antiperiodic, antipyretic, antidiabetic, anti-oxidant, anti-allergic and anti-inflammatory agent 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12. The plant had been reported for intermittent fevers and infective conditions such as typhoid, malaria, filariasis, and leprosy13,14,15,16. It had anthelmintic properties17,18, and had been prescribed for urinary disorders, skin diseases, and eye diseases19,20. It was also used to treat gout and rheumatoid arthritis21,22,23, and had cardiotonic, hematinic, expectorant, antiasthmatic, and aphrodisiac actions24, and considered as the drug of choice in clearing the microcirculatory process of human body and other body channels25. It was reported that T. cordifolia growing on Azadirectaindica A. Juss had more bioactive potential than T. cordifolia and other Tinospora sp.26. There were a lot of T. cordifolia growing on Mangiferaindica in Nakhon Pathom, Thailand. There was no report on the compounds isolated from T. cordifolia growing on M. indica. The present study investigated the antibacterial and cytotoxicity activities of major compounds isolated from ethanolic stems extract of T. cordifolia growing on Mangiferaindica and determined the best concentration of the major compounds and crude extract responsible for these activities.

    Materials & Methods

    Plant Material and Extraction Procedure

    Stems of T. cordifolia growing on M. indica were collected from the environs of Nakhon Pathom, Thailand, between September, 2017 and January, 2018. The stems were washed thoroughly 2-3 times with running water, cut into small pieces, and air dried under shade. The dried stems were then crushed in a grinder to coarse powder. Five hundred grams of powdered materials were added to 2000 ml of ethanol. The solution thus obtained was kept in an air tight flask for 24 h. The suspension was filtered using filter paper. Filtrate was evaporated at 60oC and a powdered form was obtained. The crude extract was prepared by adding methanol to obtain a stock concentration of 6 g/ml.

    Isolation of the Compounds

    The crude extract was dissolved in methanol to perform the bioautography assays27. The major compounds were isolated by silica gel 60 (230-400 mesh, Merck) column chromatography and eluted with chloroform : methanol (20:1, 15:1, 10:1, 7:1 and 5:1). Fractions were monitored by thin layer chromatography (TLC) (Kieselgel 60 F254, Merck), and spots were visualized under ultraviolet light and by heating silica gel plates sprayed with 10% H2SO4 in ethanol. The combined fractions were eluted with 60-80% chloroform in methanol by medium pressure liquid chromatography (400 x 40 mm column, Merck LiChroprep Si 60, 25-40 mm, UV-detection, 254nm) to afford fraction (fr.) A (54 mg), fr. B (98 mg) and fr. C (45 mg). The fr. C had no activity, and fr. A had low activity against tested microorganisms. Final purification of fr. B was achieved by preparative TLC (Si gel 60, 0.5 mm, Merck) to afford compound 1 (28 mg) from fr. B and compounds 2 (20 mg). The structures of purified compounds have been identified using NMR and mass spectral data. Optical rotations were measured on a Jasco P-1020 automatic digital polarimeter (Jasco International Co., Ltd., Tokyo, Japan). UV spectra were obtained using a Shimadzu UV-2401A spectrophotometer. IR spectra were recorded using a Bruker Tensor 27 FT-IR (Bruker Optics GmbH, Ettlingen, Germany) spectrophotometer with KBr pellets. NMR spectra were carried out on either a Bruker DRX-500 or an AM-400 (Bruker BioSpin GmbH, Rheinstetten, Germany) spectrometer with the deuterated solvent as an internal standard. ESI-MS (including High resolution electrospray ionisation mass spectra (HRESI-MS)) was performed on an API-Qstar-Pulsar i mass spectrometer (MDS Sciex, Concord, ON, Canada). The chemical structures of these compounds were identical with Magnoflorine (1) and Tembetarine (2) and shown in Figure 1.

    Antibacterial Assay

    An in vitro plate assay technique was used to test the inhibitory effects of the crude extract and purified compounds on the tested bacteria using the paper disk method according to Clinical Laboratory Standard Institute (CLSI)28. Sterile paper discs (6 mm, Whatman 2017-006) were loaded with 50 μl of two-fold dilution of 440 mg/ml of crude extract or 1 mg/ml of purified compounds. Four bacterial species were used in this study: Staphylococcus aureus ATCC 25932, Bacillus cereus ATCC 7064, Escherichia coli ATCC 10536, Salmonella typhimurium ATCC 23564 and Pseudomonas aeruginosa ATCC 27853 and methicillin-resistance Staphylococcus aureus SP6-106 (the clinical isolate). These bacteria were cultured in nutrient broth at 37°C for 24 h. Dilutions of bacterial suspensions were prepared using McFarland standard tubes (1 x 108 CFU/ml). The air-dried discs with various concentrations of the crude extract and purified compounds were placed on a lawn of bacterial spread on Muller Hinton agar. The plates were incubated at 37°C for 24 h. The diameter of the formed inhibition zones around each disc was recorded. The experiment was carried out in triplicate using gentamicin (30 unit/disk) (Oxoid, UK) as a reference for antimicrobial activity control.

    Minimum Inhibitory Concentration (MIC)

    The minimum inhibitory concentrations of the compound were tested against microorganisms in a 96-well microtiter plate by NCCLS microbroth dilution methods (NCCLS)29. The compound was twofold diluted from 0.5 μg/ml to 512 μg/ml, while the crude extract was twofold diluted from 0.13 mg/ml to 136.1 mg/ml, in nutrient broth supplemented with 10% glucose containing 0.01% phenol red as a colour indicator. Bacteria were adjusted to 105 CFU/ml for each microtiter plate. The microtiter plates were incubated at 37oC for 24 h. Microbial growth was determined by observing the change of colour in the wells (red to yellow when there is microbial growth). The lowest concentration that showed no change of colour was considered as the MIC, which was determined by inoculating onto nutrient agar plates 10 μl of medium from each of the wells from the MIC tests which showed no turbidity. The plates were incubated at 37°C for 24 h. Minimum bactericidal concentration (MBC) was defined as the lowest concentration of the test agent at which no microbial growth was observed on the plates.

    Cytotoxicity Activity Assay

    In order to evaluate the cytotoxicity activity of the crude extract and purified compounds, a cytotoxicity test was performed and the effects of the median inhibitory dose (IC50) on the murine fibroblast cell (L929) and embryonic kidney cell (HEK293) lines were assessed. These cell line were obtained from the Korean Cell Line Bank (Seoul, Korea). Different concentrations (1, 2, 4, 8, 16, 32, 64, 128, 256 and 512 µg/ml) of the crude extract and purified compounds were prepared and used in the cytotoxicity test. To measure cytotoxicity, 5 x 104 cells were seeded in 96-well plates and incubated in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum containing different concentrations of the test agents at 37oC for 24 h in 5% CO2 incubator. The wells were washed with a serum-free medium. Vehicle control groups were added with double distilled water.

    In the tetrazolium salt, 3-4,5 dimethylthiazol-2,5 diphenyl tetrazolium bromide (MTT) assay30, yellow MTT is reduced to purple formazan in the mitochondria of viable cells. One hundred microliters of the MTT working solution (0.5 mg/ml) was added to each well and incubated at 37oC for 5 h. Next, the media were removed, wells were washed with phosphate buffer saline and 100 μl of DMSO was added to solubilize the formazan crystalline product. The absorbance was measured with a plate reader (Packard AS10000 Spectrocount, USA) at 590 nm. The production of formazan dye was proportional to the number of viable cells.

    The inhibition of the cell lines cytotoxicity rates for each test agents with different concentrations was calculated according to the following equation:

    %Inhibition = 100 – ((Abssample - Absblank) / (Abscontrol - Absblank)) x 100

    Where Abssample is the absorbance of the test agent and Abscontrol is the absorbance of the control reaction (containing all reagents except the test agent). The %inhibition was plotted against sample concentration, and a linear regression curve was established in order to calculate the IC50. Tests were carried out in triplicate. Correlation coefficients were optimized.


    Ethanolic extract from the stems of T. cordifolia was purified by column chromatography and TLC. In the active fraction, two major compounds were isolated and identified as follows.

    Compound 1: Magnoflorine (1): C20H24NO4; white amorphous powder; UV(MeOH) lmax(log ε) = 225, 273, 309 nm; 1H-NMR (d6-DMSO): G(ppm) = 2.95 (s, 3H); 3.40 (s, 3H); 3.83 (s, 3H); 3.89 (s, 3H); 4.50 (m, 1H); 7.03 (b.s., 3H); 9.9 (m, 2H). 13C-NMR (12C-d8-DMS0): 142.2 (1); 120.9 (1a); 120.0 (1b); 148.8 (2); 110.4 (3); 120.2 (3a); 23.2 (4); 60.0 (5); 68.2 (6a);29.8(7); 125.8(7a); 119.4(8); 111.4(9); 149.3 (10); 141.6(11); 119.7(11a);42.9(N-CH3);53.1 (N-CH,); 56.1 (2-OCH3); 55.9 (10-OCH,); MS (70eV, m/e (%)): 341(1); 327(0.5); 284(0.5); 283(0.4); 270(2); 256(3); 142(10); 128(50); 127(20); 58(100).

    Compound 2: Tembetarine (2): C20H26NO4; white amorphous powder; UV(MeOH) lmax (log ε) = 210(4.45); 228sh (4.2); 284 (3.8). 'H-NMR (d6-DMSO): G(ppm) = 3.16 (s, 3H); 3.36 (s, 3H); 3.80 (s, 6H); 4.73 (m, 1H); 6.00 (s, 1H); 6.45-7.10 (m, 4H); 8.99 (s, 2H). 13C-NMR (12C-d6-DMS0): 71.1(1); 50.3 (N-CH,); 54.5(N-CH3); 50.5(3); 22.9(4); 123.2(4a); 111.6(5); 146.6(6); 146.4(7); 114.7(8); 119.0(8a); 36.7~; 128.5(1'); 116.3(2'); 144.6(3'); 147.7(4'); 112.1(5'); 120.2(6'); 55.9(6-OCH3); 55.6(4'-OCH3). MS (70 eV; m/e (%)): 343(6); 206(3); 192(100); 177(20); 149(8); 148(7); 142(17); 128(7); 127(8); 58(75). Compounds 1 and 2 were identified as magnoflorine (1) and tembetarine (2), respectively. Their 'H- and 13C-NMR spectral data were identical with those of magnoflorine and tembetarine previously reported by Pachaly and Schneider31.

    The crude extract from the stems of T. cordifolia showed a dark brown color. The crude extract yield was 12.0 g/kg while the percentage yields of the purified compounds 1 and 2 were about 0.47% and 0.33% (w/w), respectively. The antibacterial activity of the crude extract and purified compounds is summarized in Table 1. Various concentrations of crude extract and purified compounds were tested using agar disc diffusion assay. A zone of inhibition >8 mm in diameter was interpreted as sensitive. All of the susceptible strains were sensitive to the crude extract at 30 mg/disc. The crude extract showed the highest activity against B. cereus ATCC 7064, MRSA SP6-106and S. aureus ATCC 25932 at 30 mg/disc with the average zones of inhibition being 14.33 ± 2.25 mm, 15.73 ± 2.77 mm and 18.28 ± 3.68 mm, respectively. However, this crude extract showed low activity against E. coli ATCC 10536 and S. typhimurium ATCC 3564 at 30 mg/disc with the average zones of inhibition 8.33 ± 2.88 mm and 8.43 ± 2.17 mm, respectively, and also showed moderate activity against P. aeruginosa ATCC 27853 at 30 mg/disc with the average zones of inhibition 10.27 ± 2.65 mm. Compounds 1 and 2 showed the highest activity against B. cereus ATCC 7064, MRSA SP6-106and S. aureus ATCC 25932 at 50 µg/disc with the zones of inhibition ranging from 16.34 ± 4.53 mm to 19.67 ± 3.68 mm. They also showed moderate activity against P. aeruginosa ATCC 27853, E. coli ATCC 10536 and S. typhimurium ATCC 3564 at 50 µg/disc with the zones of inhibition ranging from 8.66 ± 2.31 mm to 10.50 ± 2.83 mm. Sensitive results were not obtained with discs containing 3.75-7.5 mg/disc of the crude extract and 1-5 µg/disc of compounds 1 and 2 against E. coli ATCC 10536 and S. typhimurium ATCC 3564, and 7.5 mg/disc of the crude extract and 1 µg/disc of compounds 1 and 2 against P. aeruginosa ATCC 27853.

    Table 1. Antibacterial activity of the crude extract and purified compounds on the tested microorganisms.
    Tested agents/concentrations Diameters of inhibition zones on tested microorganisms (mm)
    S.a.a B.c. E.c. S.t. P.a. MRSA
    Crude extract 3.7 mg/disc 7.33 ± 1.67 7.84 ± 1.72 NZ NZ NZ 7.71 ± 1.84
    7.5 mg/disc 8.50 ± 1.33 8.86 ± 1.64 NZ NZ 7.62 ± 1.56 8.92 ± 2.53
    15 mg/disc 10.28 ± 2.67 13.16 ± 2.54 7.72 ± 1.77 7.35 ± 1.24 8.65 ± 2.51 12.62 ± 2.86
    30 mg/disc 14.33 ± 2.25 18.28 ± 3.68 8.33 ± 2.88 8.43 ± 2.17 10.27 ± 2.65 15.73 ± 2.77
    Compound 1 1 mg/disc 8.22 ± 1.14 8.57 ± 2.13 NZ NZ NZ 8.74 ± 1.62
    5 mg/disc 8.87 ± 1.67 9.20 ± 2.38 NZ NZ 8.24 ± 2.52 9.16 ± 2.33
    10 mg/disc 13.21 ± 5.08 14.67 ± 3.92 8.34 ± 2.16 8.30 ± 2.62 9.11 ± 2.77 14.10 ± 2.36
    50 mg/disc 16.34 ± 4.53 18.88 ± 3.97 8.66 ± 2.31 8.72 ± 2.35 10.50 ± 2.83 18.21 ± 3.33
    Compound 2 1 mg/disc 7.14 ± 1.77 8.64 ± 2.65 NZ NZ NZ 8.56 ± 2.21
      5 mg/disc 8.38 ± 2.83 9.50 ± 2.76 NZ NZ 8.08 ± 2.85 8.85 ± 2.38
      10 mg/disc 12.50 ± 3.44 13.50 ± 3.33 8.21 ± 2.37 8.16 ± 2.13 8.88 ± 2.84 12.54 ± 2.82
      50 mg/disc 16.35 ± 3.88 19.67 ± 3.68 8.72 ± 2.63 8.81 ± 2.47 9.50 ± 2.77 18.51 ± 3.55
    Gentamicin 10 mg/disc 23.76 ± 1.74 22.88 ± 1.33 21.45 ± 1.61 20.74 ± 1.84 21.35 ± 1.46 23.58 ± 1.66

    aS.a.: S. aureus ATCC 25932
    B.c.: B. cereus ATCC 7064
    E.c.: E. coli ATCC 10536
    S.t.: S. typhimurium ATCC 23564
    P.a.: P. aeruginosa ATCC 27853 and
    MRSA; methicillin-resistance S. aureus SP6-106.
    The data were presented as Mean ± Standard deviation (SD). NZ = No inhibition zone.

    Adopting a classification based on MIC values proposed by Kuete32, and Kuete and Efferth33, the antibacterial activity of a plant extract is considered significant when the MICs are below 100 µg/ml, moderate when 100 ≤ MIC ≤ 512 µg/ml, and weak if MIC > 512 µg/ml. Consequently, where the activity of the crude extract showed MIC values greater than 512 µg/ml, it was therefore considered a weak inhibitor against all the test microorganisms. Compounds 1 and 2 showed the lowest MIC (32 µg/ml) against B. cereus ATCC 7064 (Table 2). These were followed by the MIC values (64 µg/ml) against MRSA SP6-106 and S. aureus ATCC 25932. Compounds 1 and 2 had high MIC values (512 µg/ml) against P. aeruginosa ATCC 27853, E. coli ATCC 10536 and S. typhimurium ATCC 3564. Compounds 1 and 2 showed the lowest MBC (128-256 µg/ml) against B. cereus ATCC 7064, MRSA SP6-106 and S. aureus ATCC 25932 whereas these compounds had high MBC values (>512 µg/ml) against P. aeruginosa ATCC 27853, E. coli ATCC 10536and S. typhimurium ATCC 3564. The crude extract had no inhibitory activity in MBC against P. aeruginosa ATCC 27853, E. coli ATCC 10536and S. typhimurium ATCC 3564.

    Table 2. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of crude extract, purified compounds on tested microorganisms.
    Tested microorganisms Antibacterial activity of the tested agents
    Crude extract (mg/ml) Compound 1 Compound 2 Chloramphenicol (mg/ml)
    (mg/ml) (mg/ml)
    S.a.a 17.01 68.05 64 256 64 256 4 512
    B.c. 8.51 68.05 32 128 32 128 8 >512
    E.c. >136.1 >136.1 512 >512 512 >512 4 >512
    S.t. >136.1 >136.1 512 >512 512 >512 8 >512
    P.a. 68.05 >136.1 512 >512 512 >512 8 >512
    MRSA 17.01 68.05 64 256 64 256 4 512

    aS.a.; S. aureus ATCC 25932
    B.c.; B. cereus ATCC 7064
    E.c.; E. coli ATCC 10536
    S.t.; S. typhimurium ATCC 23564
    P.a.; P. aeruginosa ATCC 27853
    MRSA; methicillin-resistance S. aureus SP6-106.

    To evaluate the cytotoxicity activity of the crude extract and purified compounds against L929 and HEK293, the cell lines were incubated with different doses of two-fold dilution (1-512 µg/ml) of the crude extract and purified compounds. After 24 h of incubation, cell viability was determined by MTT assay. The crude extract and purified compounds induced cell cytotoxicity in a concentration-dependent manner. The corresponding IC50 was calculated, and the results are presented in Table 3. The cytotoxicity activity of the crude extract and purified compounds was observed and showed weak cytotoxicity activity with IC50 values of 1162.24 to 2290.00 µg/ml and 1376.67 to 2585.06 µg/ml towards L929 and HEK293 cell lines, respectively.

    Table 3. IC50 of the crude extract, purified compounds against normal cell lines after 24 h using the MTT assay.
      IC50a values of crude extract, purified compounds on tested cell lines (g/ml)
    Test microorganisms L929b cells HEK293c cells
    Crude extract 2290 2585.06
    Compound 1 1162.24 1376.67
    Compound 2 1245.33 1642.81

    aIC50 values represent the concentration causing 50% growth inhibition. They were determined by linear regression analysis. bL929, murine fibroblast cell line. cHEK293, human embryonic kidney cell line.


    Medicinal properties of plant derived compounds are known to show curative activity against several bacteria and it is not surprising that the medicinal plant extracts are used traditionally by herbalists to treat bacteria related ill-health.

    T. cordifolia also exerted considerable antibacterial effect against tested pathogens. This plant has been extensively subjected to chemical investigations, and a number of chemical constituents belonging to different groups such as trepenoids, alkaloids, diterpenoid lactones, sesquiterpenoids, lignans, flavonoids, tannins, cardiac glycosides, steroids have been reported, which may account for the antimicrobial property of these agents 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52. Our research findings regarding the major compounds of T. cordifolia from Nakhon Pathom, Thailand, differ from previous reports in the literature regarding T. cordifolia from other geographical regions. Bisset and Nwaiwu53 reported that the major quaternary alkaloids in Tinospora species were generally the protoberberine bases berberine and palmatine. Nagaprashanthi et al.54 found that the hydroalcoholic extract of T. cordifolia grew over Azadirachtaindica (neem plants) has potential antimicrobial activity similar to Azadirachtaindica, and also has higher potential antimicrobial activity than the hydroalcoholic extract of T. cordifolia climbing on fencing. This may explain why the host plants (T. cordifolia) will acquire the medicinal properties when they survive on neem plants and their extracts contain more of the active compounds. In this study, therefore, the extract of T. cordifolia growing on M. indica from Nakhon Pathom, Thailand, was found to have a significantly different chemical composition from the extract of T. cordifolia from other geographical locations. This property could be attributed to exchange of bioactive constituents from M. indica to T. cordifolia, but further studies are warranted to elucidate the exact mechanisms responsible for the observed bioactive compounds. In addition, variations in the chemical composition of the extracts are known to differ considerably due to the existence of different subspecies. They might also be attributable to other factors such as climate, different regional geographic and seasonal conditions, metabolism of plants, stage of maturity and extraction conditions55. Alkaloids like berberine, palmatine, tembetarine, magnoflorine, choline, tinosporin, columbin, isocolumbin, tetrahydropalmatine have been isolated from stem and root extracts of this plant 53, 54, 55, 56, 57, 58, 59. They present numerous biological activities such as being emetic, anticholinergic, antitumor, diuretic, sympathomimetic, antiviral, antihypertensive, analgesic, antidepressant, muscle relaxant, anti-inflammatory, antimicrobial, and antiulcer60. The alkaloids have proton-accepting nitrogen atom and one or more proton-donating amine hydrogen atoms, which form hydrogen bonds with proteins, enzymes, and receptors. Furthermore, they, generally, have functional groups such as phenolic hydroxyl. The later might explain the exceptional bioactivity of the alkaloids61. In this study, major bioactive compounds; magnoflorine and tembetarine were isolated from T. cordifolia, and have antibacterial activity especially on Gram-positive bacteria. The biological activities, such as antioxidant, anti-a-glucosidase, a-tyrosinase inhibitory, anti-inflammatory, and anticancer activities, of magnoflorine have been reported. Magnoflorine from Aristolochia debilis stems showed significant antioxidant activity as a DPPH free radical scavenger, considerable a-tyrosinase inhibitory effect and also showed considerable anti-inflammatory activity in high dosage62. Hung et al.63 also have reported that, magnoflorine plays a role in protecting high-density lopoprotein (HDL) under oxidative stress. Patel and Mishra64 indicated that magnoflorine from T. cordifolia stems inhibited a-glucosidase activity. For anticancer activity, the cytotoxic effect of T. cordifolia stem extracts against cancer prostate (PC-3), colon (Colo-205, HCT-116), lung (A546, NCIH322) and breast cancer (T47D) cell lines have been reported 65, and magnoflorine has shown selected cytotoxicities against the murine leukemia (P388) cell line66. The antibacterial properties of T. cordifolia have been investigated by researchers world wide54,67,68,69. Kumar et al.70 have reported that, the crude extract from T. cordifolia leaves had antibacterial effect on E. coli. However this research found that the crude extract from T. cordifolia stems had low antibacterial activity against this microorganism. Variations in the chemical composition of the compounds are known to differ considerably not only due to the existence of different part of plants or subspecies, but might also be attributed to other factors such as climatic, geographic and seasonal condition of the regions, metabolism of plants, stage of maturity and extraction conditions55. With regard to the purified compounds, magnoflorine and tembetarine exhibited antibacterial activity that varied between bacterial species (MIC = 32 – 512 µg/ml). This differs from the report of Mushtaq et al.71. They found that magnoflorine isolated from Aquilegia fragrans exhibited weak antibacterial activity against various mastitis pathogens such as S. aureus, and Staphylococcus equorum with MIC values of 500 µg/ml.

    Tinospora and Aristolochiaplant overdoses may have serious renal side-effects. Testing the cytotoxicity of the crude extract and purified compounds was carried out on L929 and HEK293 cells. The crude extract and purified compounds showed no toxicity on both cells even at high dosage. That means, they had no cytotoxicity on L929 and HEK293 cells. This was similar to the findings of Li and Wang62, that magnoflorine had no toxicity on HEK293 and HT-29 cells at the concentration of 400 µg/ml.


    The results obtained in this study thus suggest that  the major bioactive compounds (compound 1; magnoflorine and compound 2; tembetarine) isolated from T. cordifolia have antibacterial activity especially on Gram-positive bacteria. These compounds showed bactericidal effects against B. cereus ATCC 7064, MRSA SP6-106 and S. aureus ATCC 25932 with both MIC and MBC at a concentration of 32-64 µg/ml and 128-256 µg/ml, respectively. Compounds 1 and 2 showed weak cytotoxicity activity against normal fibroblast L929 and embryonic kidney HEK293 cells and may be useful for their medicinal functions.


    This work was supported by the Department of Microbiology, Faculty of Science, Silpakorn University, Thailand.


    1.Tiwari P, Nayak P, Prusty S K, Sahu P K. (2018) Phytochemistry and Pharmacology of Tinospora cordifolia: A Review. Sys Rev Pharm. 9, 70-78.
    2. (1982) . Indigenous Drugs of India. 2nd ed. Kolkata: M/S Dhar VNSons Chopra RN, Chopra LC, Handa KD, Kapur LD .
    3.Jeyachandran R, Francis Xavier T, Anand S P. (2003) Antibacterial activity of stem extracts of Tinospora cordifolia (Wills) Hook. , F & Thomson. Anc Sci Life 23, 40-43.
    4.Nadkarni K M, Nadkarni A K. (1976) . Indian Materia Medica, 3rd ed. Mumbai: M/SPopularPrakasan Pvt Ltd, Vol 1.
    5.Patel S R, Goyal R K, Shah D S. (1977) Studies on the pharmacological effects of Tinospora cordifolia. , J Res Ind Med 13, 46.
    6.Pendse V K, Dadhich A P, Mathur P N, Bal M S, Madam B R. (1977) Anti-inflammatory, immunosuppressive and some related pharmacological actions of the water extract of Neem Giloe (Tinospora cordifolia)-A preliminary report. , Indian J Pharm 9, 221-224.
    7.Sharma A K, Singh R H. (1980) Screening of anti-inflammatory activity of certain indigenous drugs on carrageenin induced hind paw oedema in rats. , Bull Medico Ethnobot Res 1, 12.
    8.Nayampalli S S, Desai N K, Ainapure S S. (1986) Anti-allergic properties of Tinospora cardifolia in animal models. , Indian J Pharm 18, 250-252.
    9.Ikram M, Khattak S G, Gilani S N. (1987) Antipyretic studies on some indigenous Pakistani medicinal plants: II. , J Ethnopharmacol 19, 185-192.
    10.Zhao T F, Wang W, Rimando A M, Che C. (1991) Folkloric medicinal plants: Tinospora sagittata var. cravaniana and Mahonia bealei. , Planta Med 57, 505.
    11.Ramya P, Lakshmidevi N. (2010) Studies on anti-oxidant activity of Tinospora cordifolia (Miers.) leaves using in vitro models. , Journal of American Science 6, 60-64.
    12.Reddy N M, Rajasekhar R N. (2015) Tinospora cordifolia chemical constituents and medicinal properties: a review. , Sch Acad J Pharm 15, 364-369.
    13.Misra B. (1969) . (Hindi commentary by Chunekar KC.) , Bhava Prakash Nighantu 1, 269.
    14.Nayampalli S S, Ainapure S S, Nadkarni P M. (1984) Study of antiallergic acid Bronchodilator effects of Tinospora cordifolia. , Indian J Pharm 14, 64-66.
    15.Shah G L. (1984) Some Economically important plants of Salsette Island near Bombay. , J Econ Tax Bot 5, 753.
    16.Punitha D, Danya U, Udhayasankar M R, Arumugasamy K. (2012) Isolation and Characterization of the compound Fisetin from Tinospora malabarica(Miers) Ann. (Menispermaceae)- An Endengered medicinal plant. , Int J Pharm Res Dev 4, 25-32.
    17.Bindu G J, Jain V K, Shete A. (2010) Antipsychotic activity of aqueous ethanolic extract of Tinospora cordifolia in amphetamine challenged mice model. , J Adv Pharm Technol Res 1, 30-33.
    18.Nagaprashanthi C H, Aleemuddin M A, Kannan M. (2012) Investigation of in vitro anthelmintic activity of aqueous leaf extract of Tinospora cordifolia. , Int J Pharm Pharm Sci 4, 673-675.
    19.Raghunathan K, Mittra R. (1982) Pharmacognosy of Indigenous Drugs. New Delhi: Central Council for Research. In Ayurveda & Siddha .
    20.Nayampalli S S, Ainapure S S, Samant B D, Kudtarkar R G, Desai N K. (1988) A comparative study of diuretic effects of Tinospora cordifolia and hydrochlorothiazide in rats and a preliminary phase I study in human volunteers. , J Postgrad Med 34, 233-236.
    21.Charka. (1961) Charaka Samhita, Part I & II, (Hindi commentary by Pandey & Chaturvedi), edited by Rajeshwar Datta Shastri et al. , (Chaukhambha Vidyabhawan, Varanasi)
    22.Sharma P V. (Chowkhambha Vidya Bhavan, Varanasi) (1969) . , Dravya Guna Vigyan 2.
    23.Vaagbhata. (1982) Ashtanghridayam, Commentary by Arunadatta & Hemaadri, collected by Kunt & Narvare and edited by Paradkara. , (Chaukhambha Orientalia, Varanasi & Delhi)
    24.Prashant T, Kumar B, Kaur M, Pardeep D J. (2011) Comparative anthelmintic activity of aqueous and ethanolic stem extract of Tinospora cordifolia. , Int J Drug Dev Res 3, 70-83.
    25.Dahiya D, Srinivasan K K, Subburaju T, Gurav S. (2011) Tinospora cordifolia: A Review on its Ethnobotany, Phytochemical and Pharmacological Profile. , Asian J Biochem Pharm Res 4, 291-302.
    26.Watt G A. (1972) Dictionary of economic products of India. Reprinted edition, (Periodical Experts , Delhi) 6.
    27.Suleimana M M, McGaw L J, Naidoo V, Eloff J N. (2010) Detection of antimicrobial compounds by bioautography of different extracts of leaves of selected South African tree species. , Afr J Tradit Complement Altern Med 7, 64-78.
    28.CLSI. Clinical Laboratory Standard Institute (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A9. Clinical and Laboratory Standards Institute , Wayne, PA, USA .
    29.NCCLS National.Committee for Clinical Laboratory Standards (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard M7-A5. National Committee for Clinical Laboratory Standards. , Wayne, PA, USA
    30.Taechowisan T, Chaisaeng S, Phutdawong W S. (2017) Antibacterial, antioxidant and anticancer activities of biphenyls from Streptomyces sp. BO-07; An endophyte in Boesenbergia rotunda (L.) Mansf A. Food Agric Immunol. 28, 1330-1346.
    31.Pachaly P, Schneider C. (1981) Alkaloide aus Tinospora cordifolia Miers. Arch Pharm (Weinheim). 314, 251-256.
    32.Kuete V. (2010) Potential of Cameroonian plants and derived products against microbial infections: a review. , Planta Med 76, 1479-1491.
    33.Kuete V, Efferth T. (2010) Cameroonian medicinal plants: pharmacology and derived natural products. , Front Pharmacol 1, 123.
    34.Hanuman J B, Bhatt R K, Sabata B K. (1986) A diterpenoid furanolactonefrom Tinospora cordifolia. , Phytochemistry 25, 1677-1680.
    35.Bhatt R K, Hanuman J B, Sabata B K. (1988) A new clerodane derivative from Tinospora cordifolia. , Phytochemistry 27, 1212-1216.
    36.Bhatt R K, Sabata B K. (1989) A furanoid diterpene glucoside from Tinospora cordifolia. , Phytochemistry 28, 2419-2422.
    37.Khan M A, Gray A I, Waterman P G. (1989) Tinosporaside, an 18-Norclerodane glucoside from Tinospora cordifolia. , Phytochemistry 28, 273-275.
    38.Sipahimalani A, Norr H, Wagner H. (1994) glycosides and tetrahydrofuranlignan glycosides from the adaptogenic plant drugs Tinospora cordifolia and Drypetes roxburghii. , Planta Med 60, 596-597.
    39.Gangan V D, Pradhan P, Sipahimalani A T, Banerji A. (1994) Cordifolisides A, B, C: Norditerpene furan glycosides from Tinospora cordifolia. , Phytochemistry 37, 781-786.
    40.Wazir V, Maurya R, Kapil R S. (1995) Cordioside, a clerodane furano diterpene glucoside from Tinospora cordifolia. , Phytochemistry 38, 447-449.
    41.Maurya R, Wazir V, Tyagi A, Kapil R S. (1995) Clerodane diterpenoids from Tinosporacordifolia. , Phytochemistry 38, 659-661.
    42.Maurya R, Handa S S. (1998) Tinocordifolin a sesquiterpene from Tinospora cordifolia. , Phytochemistry 49, 1343-1345.
    43.Desai S, Metrani R, Vantamuri S, Ginigeri V, Phadke K. (2012) Phytochemical analysis, antimicrobial and antitumour screening of endophytes of Tinospora cordifolia. , Int J Pharm Bio Sci 3, 533-540.
    44.Gupta A K, Tandon N, Sharma M. Indian Council of Medical Research, India (2003) . , Quality Standards of IndianMedicinal Plants 1.
    45.Singh S S, Pandey S C, Srivastava S, Gupta V S, Patro B. (2003) Chemistry and medicinal properties of Tinospora cordifolia (guduchi). , Indian J Pharmacol 35, 83-91.
    46.Gopi M, Shrikumar S, Ravi T K. (2004) Tinospora cordifolia (Amrita): An Important Ayurvedic Plant. Department of Pharmaceutical Analysis. , College of Pharmacy, SRIPMS, Coimbatore
    47.Sinha K, Mishra N P, Singh J, SPS Khanuja. (2004) Tinospora cordifolia (Guduchi), a reservoir plant for therapeutic applications: a review. , Indian J Traditional Knowledge 3, 257-270.
    48.Iqbal J, Hussain A, Gupta A. (2005) Sensitized photooxygenation of tinosponone, a clerodane diterpene from Tinospora cordifolia. , Acta Chem Solv 52, 455-459.
    49.Jagetia G C, Rao S K. (2006) Evaluation of cytotoxic effects of dichloromethane extract of guduchi (Tinospora cordifolia Miers ex Hook F & Thoms) on cultured HeLa cells. , Evidence-Based Complement Altern Med 3, 267-272.
    50.Bansal D, Bhasin P, Punia A, Sehrawat A R. (2012) Evaluation of antimicrobial activity and phytochemical screening of extracts of Tinospora cordifolia against some pathogenic microbes. , J Pharm Res 5, 127-129.
    51.Patil R C, Kulkarni C P, Pandey A. (2017) Antibacterial and phytochemical analysis of Tinospora cordifolia, Azarchita indica and Ocimum santum leaves extract against common human pathogens: an in vitro study. , JPharmacogn Phytochem 6, 702-706.
    52.Sinku R, Sinha M R. (2018) Preliminary phytochemical screening and physiochemical analysis of Tinospora cordifolia Miers. , J Med Plants Stud 6, 177-180.
    53.Bisset N G, Nwaiwu J. (1983) Quaternary alkaloids of Tinospora species. , Planta Med 48, 275-279.
    54.Nagaprashanthi C H, Rafi K P, Gopi C K, Aleemuddin M A, Rajiya B G. (2012) In vitro antimicrobial activity of Tinospora cordifolia and its phytochemical screening. , Int J Pharmtech Res 4, 1004-1008.
    55.Anwar F, Ali M, Hussain A I, Shahid M. (2009) Antioxidant and antimicrobial activities of essential oil and extracts of fennel (Foeniculum vulgare Mill.) seeds from Pakistan. Flavour Fragr. , J 24, 170-176.
    56.Padhya M A. (1986) Biosynthesis of isoquinone alkaloid-berberine in tissue culture of Tinospora cordifolia. , Indian Drugs 24, 47-48.
    57.DNK Sarma, Padma P, Khosa R L. (1998) Constituents of Tinospora cordifolia root. , Fitoterapia 69, 541-542.
    58.Rao B R, Kumar D V, Amrutha R N, Jalaja N, Vaidyanath K. (2008) Effect of growth regulators, carbon source and cell aggregate size on berberine production from cell cultures of Tinospora cordifolia Miers. Curr Trends Biotechnol Pharm. 2, 269-276.
    59.Srinivasan G V, Unnikrishnan K P, Shree A B, Balachandran I. (2008) HPLC estimation of berberine in Tinospora cordifolia and Tinospora sinensis. , Indian J Pharm Sci 70, 96-99.
    60.Ahmad W, Jantan I, SNA Bukhari. (2016) Tinospora crispa (L.) Hook. f. & Thomson: a review of its ethnobotanical, phytochemical, and pharmacological aspects. , Front Pharmacol 7, 59.
    61.TPT Cushnie, Cushnie B, Lamb A J. (2014) Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities. , Int J Antimicrob Agents 44, 377-386.
    62.Li C, Wang M H. (2014) Potential Biological Activities of Magnoflorine: A compound from Aristolochia debilis Sieb. Et Zucc. , Korean J Plant Res 27, 223-228.
    63.Hung T M, Lee J P, Min B S, Choi J S, Na M. (2007) Magnoflorine from Coptidis rhizoma protects high density lipoprotein during oxidant stress. , Biol Pharm Bull 30, 1157-1160.
    64.Patel M B, Mishra S M. (2012) Magnoflorine from Tinospora cordifolia stem inhibits α-glucosidase and is antiglycemic in rats. , J Funct Foods 4, 79-86.
    65.Sharma A K, Kumar S, Pandey A K. (2014) Ferric reducing, anti-radical and cytotoxic activities of Tinospora cordifolia stem extracts. , Biochem Anal Biochem 3, 153-158.
    66.Stévigny C, Bailly C, Leclercq J Q. (2005) Cytotoxic and antitumoor potentialities of aporphinoid alkaloids. , Curr Med Chem Anticancer Agents 5, 173-182.
    67.Mahesh B, Sathish S. (2008) Antimicrobial activity of some important medicinal plants against plant and human pathogens. , World J Agric Sci 4, 839-843.
    68.Bonvicini F, Mandrone M, Antognoni F, Poli F, Gentilomi G A. (2010) Ethanolic extracts of Tinospora cordifolia and Alstonia scholaris show antimicrobial activity towards clinical isolates of methicillin resistant and carbapenemase-producing bacteria. , Nat Prod Res 28, 1438-1445.
    69.Veeramuthu D, Savarimuthu I, Kedike B. (2012) Antimicrobial activity of Tinospora cordifolia: an ethanomedicinal plant. , Asian J Tradit Med 7, 59-65.
    70.Kumar D V, Geethanjali B, Avinash K O, Kumar J R, Chandrashekrappa G K. (2017) Tinospora cordifolia: The antimicrobial property of the leaves of Amruthaballi. , J Bacteriol Mycol 5, 147-156.
    71.Mushtaq S, Aga M A, Qazi P H, Ali M N, Shah A M. (2016) Isolation, characterization and HPLC quantification of compounds from Aquilegia fragrans Benth: Their in vitro antibacterial activities against bovine mastitis pathogens. , J Ethnopharmacol 178, 9-12.